Silexion Therapeutics Corp (NASDAQ:SLXN) does about 5.90M shares in volume on a normal day but saw 1812541 shares change hands in the recent trading day. The company now has a market cap of 4.62M USD. Its current market price is $0.32, marking an increase of 4.07% compared to the previous close of $0.31. The 52 week high reached by this stock is $13.56 whilst the lowest price level in 52 weeks is $0.21.
Silexion Therapeutics Corp (SLXN) has a 20-day trading average at $0.2697 and the current price is -97.64% off the 52-week high compared with 54.59% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3894. If we look at the stock’s price movements over the week, volatility stands at 33.80%, which decreases to 16.72% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 43.49 to suggest the stock is neutral.
The consensus objective for the share price is $1.00, suggesting that the stock has a potential upside of 68.0% over the period.
The current price level is 18.66%, -17.83%, and -95.58% away from its SMA20, SMA50, and SMA200 respectively, with the SLXN price moving above the 50-day SMA on current market day. Silexion Therapeutics Corp (SLXN) stock is up 41.47% over the week and 8.47% over the past month. Its price is -97.05% year-to-date and -96.79% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 68.0 percent from here.
Outstanding shares total 3.87M with insiders holding 33.99% of the shares and institutional holders owning 8.50% of the company’s common stock. The company has a return on investment of -20.64% and return on equity of -3.78%. The beta has a value of -0.07. Price to book ratio is 0.49.
